BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 33189038)

  • 1. Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy.
    Ren Q; Meng X; Zhang B; Zhang J; Shuai X; Nan X; Zhao C
    Parkinsonism Relat Disord; 2020 Dec; 81():194-199. PubMed ID: 33189038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Parkinson's disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging.
    Ren Q; Wang Y; Xia X; Zhang J; Zhao C; Meng X
    Front Hum Neurosci; 2022; 16():806122. PubMed ID: 35982687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.
    Bu S; Pang H; Li X; Zhao M; Wang J; Liu Y; Yu H
    BMC Med Imaging; 2023 Dec; 23(1):204. PubMed ID: 38066432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks.
    Tsuda M; Asano S; Kato Y; Murai K; Miyazaki M
    J Neurol Sci; 2019 Jun; 401():19-26. PubMed ID: 31005759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
    Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Parkinsonism-Predominant Multiple System Atrophy from Idiopathic Parkinson Disease Using 3T Susceptibility-Weighted MR Imaging, Focusing on Putaminal Change and Lesion Asymmetry.
    Hwang I; Sohn CH; Kang KM; Jeon BS; Kim HJ; Choi SH; Yun TJ; Kim JH
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2227-34. PubMed ID: 26338919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study.
    Cui X; Li L; Yu L; Xing H; Chang H; Zhao L; Qian J; Song Q; Zhou S; Dong C
    Clinics (Sao Paulo); 2020; 75():e1505. PubMed ID: 32555945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping.
    Ito K; Ohtsuka C; Yoshioka K; Kameda H; Yokosawa S; Sato R; Terayama Y; Sasaki M
    Neuroradiology; 2017 Aug; 59(8):759-769. PubMed ID: 28689259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H; Granberg T; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.